e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP)
A. Strassburg, G. Van Zandbergen, H. Kothe, A. Wulf, J. Braun, K. Dalhoff (Luebeck, Germany)
Source:
Annual Congress 2002 - Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Session:
Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Session type:
Poster Discussion
Number:
2665
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Strassburg, G. Van Zandbergen, H. Kothe, A. Wulf, J. Braun, K. Dalhoff (Luebeck, Germany). Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP). Eur Respir J 2002; 20: Suppl. 38, 2665
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Related content which might interest you:
Enhanced PMN response in chronic bronchitis and community-acquired pneumonia
Source: Eur Respir J 2004; 24 : 772-778
Year: 2004
Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011
Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007
How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?
Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Year: 2015
Detection of liver function in patients with severe community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 15s
Year: 2002
Macrophage activation in exacerbated COPD with and without community-acquired pneumonia
Source: Eur Respir J 2010; 36: 285
Year: 2010
Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 106s
Year: 2006
Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Comparison of costs of community-acquired pneumonia (CAP) treatment at patients with and without bronchial obstruction
Source: Annual Congress 2011 - COPD management
Year: 2011
Impact of neutrophil function on outcomes of community-acquired pneumonia (CAP) in patients with cancer
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Community-acquired pneumonia (CAP) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003
Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005
COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006
Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
Lower respiratory tract infections: when are antibiotics mandatory?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146
Year: 2004
Corticosteroids in severe pneumonia
Source: Eur Respir J 2008; 32: 259-264
Year: 2008
Level of hypoferremia at patients with community-acquired pneumonia (CAP) and lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 438s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept